Key result
Review highlights inflammatory mechanisms and innate immune cell programming driving atherosclerosis.
Answers are grounded in this paper and cite their sources.
This review highlights the emerging role of trained immunity and inflammatory programming in driving residual cardiovascular risk in atherosclerotic cardiovascular disease.
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality worldwide despite major advances in risk factor attenuation and lipid-lowering therapies. Inflammation is a central driver of atherosclerosis, contributing to disease initiation, progression, and excess cardiovascular risk. This article summarizes the pathophysiology of atherosclerosis with a focus on the inflammatory mechanisms underlying plaque development and instability, anti-inflammatory therapeutic strategies, and the emerging role of epigenetic and metabolic programming of innate immune cells in perpetuating unresolved inflammation.
No takes yet. Share an insight, caveat, or question.
Nazari et al. (2026) conducted a review in Atherosclerotic cardiovascular disease (ASCVD). This review summarizes the pathophysiology of atherosclerosis, focusing on inflammatory mechanisms, anti-inflammatory therapies, and the role of epigenetic and metabolic programming of innate immune cells.
Synapse has enriched 10 related papers. Consider them for comparative context: